Cumulative neurobehavioral and physiological effects of chronic caffeine intake: Individual differences and implications for the use of caffeinated energy products

Nutrition Reviews

Volumn 72, Issue S1, 2014, Pages 34-47

  Spaeth, Andrea M ^a   Goel, Namni ^b   Dinges, David F ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Alertness; Caffeine; Circadian rhythm; Energy drinks; Fatigue

Indexed keywords

CAFFEINE; CENTRAL STIMULANT AGENT;

ALERTNESS; ARTICLE; ATTENTION; CIRCADIAN RHYTHM; COGNITION; DIETARY INTAKE; ENERGY DRINK; FATIGUE; HEREDITY; HUMAN; LONG TERM EXPOSURE; MEMORY; MOOD; PHYSICAL PERFORMANCE; SLEEP DEPRIVATION; SLEEP DISORDER; SLEEP INERTIA; SLEEP TIME; TASK PERFORMANCE; TIME ON TASK EFFECT; WAKEFULNESS; DRUG EFFECTS; DRUG THERAPY; PERSONALIZED MEDICINE; SLEEP;

ATTENTION; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CIRCADIAN RHYTHM; ENERGY DRINKS; FATIGUE; HUMANS; PRECISION MEDICINE; SLEEP; SLEEP DEPRIVATION;

EID: 84907822258     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/nure.12151     Document Type: Article

References (208)

1. Malinauskas BM, Aeby VG, Overton RF, etal. Survey of energy drink consumption patterns among college students. Nutr J. 2007;6:35. doi:10.1186/1475-2891-6-35.
2. Toblin RL, Clarke-Walper K, Kok BC, etal. Energy drink consumption and its association with sleep problems among U.S. service members on a combat deployment - Afghanistan, 2010. MMWR. 2012;61:895-898.
3. McLellan TM, Lieberman HR. Do energy drinks contain active components other than caffeine? Nutr Rev. 2012;70:730-744.
4. Dinges DF. Stress, fatigue, and behavioral energy. Nutr Rev. 2001;59:S30-S32.
5. Seidl R, Peyrl A, Nicham R, etal. A taurine and caffeine-containing drink stimulates cognitive performance and well-being. Amino Acids. 2000;19:635-642.
6. Alford C, Cox H, Wescott R. The effects of Red Bull Energy Drink on human performance and mood. Amino Acids. 2001;21:139-150.
7. Kennedy DO, Scholey AB. A glucose-caffeine "energy drink" ameliorates subjective and performance deficits during prolonged cognitive demand. Appetite. 2004;42:331-333.
8. Scholey AB, Kennedy DO. Cognitive and physiological effects of an "energy drink": an evaluation of the whole drink and of glucose, caffeine and herbal flavouring fractions. Psychopharmacology. 2004;176:320-330.
9. Smit HJ, Cotton JR, Hughes SC, etal. Mood and cognitive performance effects of "energy" drink constituents: caffeine, glucose and carbonation. Nutr Neurosci. 2004;7:127-139.
10. Rao A, Hu H, Nobre AC. The effects of combined caffeine and glucose drinks on attention in the human brain. Nutr Neurosci. 2005;8:141-153.
11. Childs E, de Wit H. Enhanced mood and psychomotor performance by a caffeine-containing energy capsule in fatigued individuals. Exp Clin Psychopharmacol. 2008;16:13-21.
12. Howard MA, Marczinski CA. Acute effects of a glucose energy drink on behavioral control. Exp Clin Psychopharmacol. 2010;18:553-561.
13. Sunram-Lea SI, Owen-Lynch J, Robinson SJ, etal. The effect of energy drinks on cortisol levels, cognition and mood during a fire-fighting exercise. Psychopharmacology. 2012;219:83-97.
14. Wesnes KA, Barrett ML, Udani JK. An evaluation of the cognitive and mood effects of an energy shot over a 6h period in volunteers: a randomized, double-blind, placebo controlled, cross-over study. Appetite. 2013;67:105-113.
15. Heckman MA, Weil J, Gonzalez de Mejia E. Caffeine (1, 3, 7-trimethylxanthine) in foods: a comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci. 2010;75:R77-R87.
16. Giles GE, Mahoney CR, Brunye TT, etal. Differential cognitive effects of energy drink ingredients: caffeine, taurine, and glucose. Pharmacol Biochem Behav. 2012;102:569-577.
17. Peacock A, Martin FH, Carr A. Energy drink ingredients: contribution of caffeine and taurine to performance outcomes. Appetite. 2013;64:1-4.
18. Pettitt RW, Niemeyer JD, Sexton PJ, etal. Do the noncaffeine ingredients of energy drinks affect metabolic responses to heavy exercise? J Strength Cond Res. 2013;27:1994-1999.
19. Nehlig A, Daval JL, Debry G. Caffeine and the central nervous system: mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res Rev. 1992;17:139-170.
20. Kamimori GH, Karyekar CS, Otterstetter R, etal. The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers. Int J Pharm. 2002;234:159-167.
21. Ribeiro JA, Sebastiao AM. Caffeine and adenosine. J Alzheimers Dis. 2010;20(Suppl 1):S3-S15.
22. Scharf MT, Naidoo N, Zimmerman JE, etal. The energy hypothesis of sleep revisited. Prog Neurobiol. 2008;86:264-280.
23. Porkka-Heiskanen T, Kalinchuk AV. Adenosine, energy metabolism and sleep homeostasis. Sleep Med Rev. 2011;15:123-135.
24. Benowitz NL. Clinical pharmacology of caffeine. Annu Rev Med. 1990;41:277-288.
25. Astrup A, Toubro S, Cannon S, etal. Caffeine: a double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers. Am J Clin Nutr. 1990;51:759-767.
26. Borbely AA. Processes underlying sleep regulation. Horm Res. 1998;49:114-117.
27. Daan S, Beersma DGM, Borbely AA. Timing of human sleep - recovery process gated by a circadian pacemaker. Am J Physiol. 1984;246:R161-R178.
28. McCauley P, Kalachev LV, Smith AD, etal. A new mathematical model for the homeostatic effects of sleep loss on neurobehavioral performance. J Theor Biol. 2009;256:227-239.
29. Cajochen C, Khalsa SB, Wyatt JK, etal. EEG and ocular correlates of circadian melatonin phase and human performance decrements during sleep loss. Am J Physiol. 1999;277:R640-R649.
30. Van Dongen HP, Vitellaro KM, Dinges DF. Individual differences in adult human sleep and wakefulness: leitmotif for a research agenda. Sleep. 2005;28:479-496.
31. Krueger PM, Friedman EM. Sleep duration in the United States: a cross-sectional population-based study. Am J Epidemiol. 2009;169:1052-1063.
32. Knutson KL, Van Cauter E, Rathouz PJ, etal. Trends in the prevalence of short sleepers in the USA: 1975-2006. Sleep. 2010;33:37-45.
33. Luckhaupt SE, Tak S, Calvert GM. The prevalence of short sleep duration by industry and occupation in the National Health Interview Survey. Sleep. 2010;33:149-159.
34. Basner M, Fomberstein KM, Razavi FM, etal. American time use survey: sleep time and its relationship to waking activities. Sleep. 2007;30:1085-1095.
35. Hale L. Who has time to sleep? J Public Health Med. 2005;27:205-211.
36. Virtanen M, Ferrie JE, Gimeno D, etal. Long working hours and sleep disturbances: the Whitehall II prospective cohort study. Sleep. 2009;32:737-745.
37. Nakashima M, Morikawa Y, Sakurai M, etal. Association between long working hours and sleep problems in white-collar workers. J Sleep Res. 2010;20:110-116.
38. Aeschbach D, Cajochen C, Landolt H, etal. Homeostatic sleep regulation in habitual short sleepers and long sleepers. Am J Physiol. 1996;270:R41-R53.
39. Klerman EB, Dijk DJ. Interindividual variation in sleep duration and its association with sleep debt in young adults. Sleep. 2005;28:1253-1259.
40. Bradshaw DA, Yanagi MA, Pak ES, etal. Nightly sleep duration in the 2-week period preceding multiple sleep latency testing. J Clin Sleep Med. 2007;3:613-619.
41. Carskadon MA, Dement WC. Cumulative effects of sleep restriction on daytime sleepiness. Psychophysiology. 1981;18:107-113.
42. Dinges DF, Pack F, Williams K, etal. Cumulative sleepiness, mood disturbance, and psychomotor vigilance performance decrements during a week of sleep restricted to 4-5 hours per night. Sleep. 1997;20:267-277.
43. Belenky G, Wesensten NJ, Thorne DR, etal. Patterns of performance degradation and restoration during sleep restriction and subsequent recovery: a sleep dose-response study. J Sleep Res 2003;12:1-12.
44. Rupp TL, Wesensten NJ, Bliese PD, etal. Banking sleep: realization of benefits during subsequent sleep restriction and recovery. Sleep. 2009;32:311-321.
45. Banks S, Van Dongen HPA, Maislin G, etal. Neurobehavioral dynamics following chronic sleep restriction: dose-response effects of one night for recovery. Sleep. 2010;33:1013-1026.
46. Van Dongen HP, Maislin G, Mullington JM, etal. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep. 2003;26:117-126.
47. Goel N, Banks S, Mignot E, etal. PER3 polymorphism predicts cumulative sleep homeostatic but not neurobehavioral changes to chronic partial sleep deprivation. PLoS ONE. 2009;4:e5874. doi:10.1371/journal.pone.0005874.
48. Wu H, Stone WS, Hsi X, etal. Effects of different sleep restriction protocols on sleep architecture and daytime vigilance in healthy men. Physiol Res. 2010;59:821-829.
49. Thacher PV. University students and "the all nighter": correlates and patterns of students' engagement in a single night of total sleep deprivation. Behav Sleep Med. 2008;6:16-31.
50. Baldwin DC, Daugherty SR. Sleep deprivation and fatigue in residency training: results of a national survey of first- and second-year residents. Sleep. 2004;27:217-223.
51. Philip P, Taillard J, Leger D, etal. Work and rest sleep schedules of 227 European truck drivers. Sleep Med. 2002;3:507-511.
52. Wright KP Jr, Bogan RK, Wyatt JK. Shift work and the assessment and management of shift work disorder (SWD). Sleep Med Rev. 2013;17:41-54.
53. Rosenthal L, Roehrs TA, Rosen A, etal. Level of sleepiness and total sleep time following various time in bed conditions. Sleep. 1993;16:226-232.
54. Harma M, Suvanto S, Popkin S, etal. A dose-response study of total sleep time and the ability to maintain wakefulness. J Sleep Res. 1998;7:167-174.
55. Doran SM, Van Dongen HPA, Dinges DF. Sustained attention performance during sleep deprivation: evidence of state instability. Arch Ital Biol. 2001;139:253-267.
56. Akerstedt T, Torsvall L, Gillberg M. Sleepiness in shiftwork - a review with emphasis on continuous monitoring of EEG and EOG. Chronobiol Int. 1987;4:129-140.
57. Torsvall L, Akerstedt T. Sleepiness on the job: continuously measured EEG changes in train drivers. Electroencephalogr Clin Neurophysiol. 1987;66:502-511.
58. Saper CB, Scammell TE, Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature. 2005;437:1257-1263.
59. Lim J, Dinges DF. Sleep deprivation and vigilant attention. Ann N Y Acad Sci. 2008;1129:305-322.
60. Kleitman N. Sleep and Wakefulness. Chicago: University of Chicago; 1963.
61. Dinges DF, Kribbs NB. Performing while sleepy: effects of experimentally-induced sleepiness. In: Monk TH, ed. Sleep, Sleepiness and Performance. Chister: Wiley; 1991:97-128.
62. Harrison Y, Horne JA. Occurrence of "microsleeps" during daytime sleep onset in normal subjects. Electroencephalogr Clin Neurophysiol. 1996;98:411-416.
63. Sadun AA, Schaechter JD, Smith LEH. A retinohypothalamic pathway in man - light mediation of circadian rhythms. Brain Res. 1984;302:371-377.
64. Ralph MR, Foster RG, Davis FC, etal. Transplanted suprachiasmatic nucleus determines circadian period. Science. 1990;247:975-978.
65. Watts AG. The efferent projections of the suprachiasmatic nucleus: anatomical insights into the control of circadian rhythms. In: Klein DC, Moore RY, Reppert SM, eds. Suprachiasmatic Nucleus: The Mind's Clock. New York: Oxford University Press; 1991:77-106.
66. Czeisler CA. The effect of light on the human circadian pacemaker. Ciba Found Symp. 1995;183:254-290.
67. Lucas RJ, Stirland JA, Darrow JM, etal. Free running circadian rhythms of melatonin, luteinizing hormone, and cortisol in Syrian hamsters bearing the circadian tau mutation. Endocrinology. 1999;140:758-764.
68. Aschoff J, Wever R. The circadian system of man. In: Aschoff J, ed. Handbook of Behavioral Neurobiology. Vol. 4. New York: Plenum Press; 1981:311-331.
69. Shanahan TL, Czeisler CA. Light exposure induces equivalent phase shifts of the endogenous circadian rhythms of circulating plasma melatonin and core body temperature in men. J Clin Endocrinol Metab. 1991;73:227-235.
70. Czeisler CA, Duffy JF, Shanahan TL, etal. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science. 1999;284:2177-2181.
71. Lack LC, Lushington K. The rhythms of human sleep propensity and core body temperature. J Sleep Res. 1996;5:1-11.
72. Monk TH. The post-lunch dip in performance. Clin Sports Med. 2005;24:e15-e23.
73. Shekleton JA, Rajaratnam SM, Gooley JJ, etal. Improved neurobehavioral performance during the wake maintenance zone. J Clin Sleep Med. 2013;9:353-362.
74. Goel N, Basner M, Rao H, etal. Circadian rhythms, sleep deprivation, and human performance. Prog Mol Biol Transl Sci. 2013;119:155-190.
75. Langdon DE, Hartman B. Performance upon sudden awakening. Tech Doc Rep SAMTDR USAF Sch Aerosp Med. 1961;62-17:8p.
76. Lubin A, Hord DJ, Tracy ML, etal. Effects of exercise, bedrest and napping on performance decrement during 40 hours. Psychophysiology. 1976;13:334-339.
77. Dinges DF, Orne EC, Evans FJ, etal. Performance after naps in sleep-conducive and alerting environments. In: Johnson LC, Tepas DI, Colquhoun WP, etal., eds. Biological Rhythms, Sleep and Shift Work. New York: Spectrum; 1981:539-552.
78. Jewett ME, Wyatt JK, Ritz-De Cecco A, etal. Time course of sleep inertia dissipation in human performance and alertness. J Sleep Res. 1999;8:1-8.
79. Wertz AT, Ronda JM, Czeisler CA, etal. Effects of sleep inertia on cognition. JAMA. 2006;295:163-164.
80. Tassi P, Muzet A. Sleep inertia. Sleep Med Rev 2000;4:341-353.
81. Lovato N, Lack L. The effects of napping on cognitive functioning. Prog Brain Res. 2010;185:155-166.
82. Matchock RL. Circadian and sleep episode duration influences on cognitive performance following the process of awakening. Int Rev Neurobiol. 2010;93:129-151.
83. Lavie P, Weler B. Timing of naps: effects on post-nap sleepiness levels. Electroencephalogr Clin Neurophysiol. 1989;72:218-224.
84. Dinges DF, Orne MT, Orne EC. Assessing performance upon abrupt awakening from naps during quasi-continuous operations. Behav Res Methods Instrum Comput. 1985;17:37-45.
85. Webb WB, Agnew H. Reaction time and serial response efficiency on arousal from sleep. Percept Mot Skills. 1964;18:783-784.
86. Silva EJ, Duffy JF. Sleep inertia varies with circadian phase and sleep stage in older adults. Behav Neurosci. 2008;122:928-935.
87. Mackworth JF. Vigilance, arousal, and habituation. Psychol Rev. 1968;75:308-322.
88. Frankmann JP, Adams JA. Theories of vigilance. Psychol Bull. 1962;59:257-272.
89. Grier RA, Warm JS, Dember WN, etal. The vigilance decrement reflects limitations in effortful attention, not mindlessness. Hum Factors. 2003;45:349-359.
90. Smit AS, Eling PA, Coenen AM. Mental effort causes vigilance decrease due to resource depletion. Acta Psychol (Amst). 2004;115:35-42.
91. Warm JS, Parasuraman R, Matthews G. Vigilance requires hard mental work and is stressful. Hum Factors. 2008;50:433-441.
92. Lorist MM, Boksem MA, Ridderinkhof KR. Impaired cognitive control and reduced cingulate activity during mental fatigue. Brain Res Cogn Brain Res. 2005;24:199-205.
93. Lim J, Wu WC, Wang JJ, etal. Imaging brain fatigue from sustained mental workload: an ASL perfusion study of the time-on-task effect. Neuroimage. 2010;49:3426-3435.
94. Faber LG, Maurits NM, Lorist MM. Mental fatigue affects visual selective attention. PLoS ONE. 2012;7:e48073. doi:10.1371/journal.pone.0048073.
95. Foxe JJ, Morie KP, Laud PJ, etal. Assessing the effects of caffeine and theanine on the maintenance of vigilance during a sustained attention task. Neuropharmacology. 2012;62:2320-2327.
96. Wilkinson RT. Effects of up to 60 hours' sleep deprivation on different types of work. Ergonomics. 1964;7:175-186.
97. Angus RG, Heslegrave RJ. Effects of sleep loss on sustained cognitive performance during a command and control simulation. Behav Res Methods Instrum Comput. 1985;17:55-67.
98. Steyvers FJ, Gaillard AW. The effects of sleep deprivation and incentives on human performance. Psychol Res. 1993;55:64-70.
99. Wesensten NJ, Belenky G, Thorne DR, etal. Modafinil vs. caffeine: effects on fatigue during sleep deprivation. Aviat Space Environ Med. 2004;75:520-525.
100. Valdez P, Ramirez C, Garcia A, etal. Circadian and homeostatic variation in sustained attention. Chronobiol Int. 2010;27:393-416.
101. Bergum BO, Lehr DJ. Vigilance performance as a function of interpolated rest. J Appl Psychol. 1962;46:425-427.
102. Loke WH. Effects of caffeine on mood and memory. Physiol Behav. 1988;44:367-372.
103. Kelly TL, Mitler MM, Bonnet MH. Sleep latency measures of caffeine effects during sleep deprivation. Electroencephalogr Clin Neurophysiol. 1997;102:397-400.
104. Wright KP, Badia P, Myers BL, etal. Combination of bright light and caffeine as a countermeasure for impaired alertness and performance during extended sleep deprivation. J Sleep Res. 1997;6:26-35.
105. Beaumont M, Batejat D, Pierard C, etal. Slow release caffeine and prolonged (64-h) continuous wakefulness: effects on vigilance and cognitive performance. J Sleep Res. 2001;10:265-276.
106. Lieberman HR, Tharion WJ, Shukitt-Hale B, etal. Effects of caffeine, sleep loss, and stress on cognitive performance and mood during US Navy SEAL training. Psychopharmacology. 2002;164:250-261.
107. Wesensten NJ, Belenky G, Kautz MA, etal. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine. Psychopharmacology. 2002;159:238-247.
108. Kamimori GH, Johnson D, Thorne D, etal. Multiple caffeine doses maintain vigilance during early morning operations. Aviat Space Environ Med. 2005;76:1046-1050.
109. McLellan TM, Kamimori GH, Bell DG, etal. Caffeine maintains vigilance and marksmanship in simulated urban operations with sleep deprivation. Aviat Space Environ Med. 2005;76:39-45.
110. Wesensten NJ, Killgore WDS, Balkin TJ. Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation. J Sleep Res. 2005;14:255-266.
111. Killgore WDS, Rupp TL, Grugle NL, etal. Effects of dextroamphetamine, caffeine and modafinil on psychomotor vigilance test performance after 44h of continuous wakefulness. J Sleep Res. 2008;17:309-321.
112. Rosenthal L, Roehrs T, Zwyghuizen-Doorenbos A, etal. Alerting effects of caffeine after normal and restricted sleep. Neuropsychopharmacology. 1991;4:103-108.
113. Smith AP, Clark R, Gallagher J. Breakfast cereal and caffeinated coffee: effects on working memory, attention, mood, and cardiovascular function. Physiol Behav. 1999;67:9-17.
114. Reyner LA, Horne JA. Early morning driver sleepiness: effectiveness of 200mg caffeine. Psychophysiology. 2000;37:251-256.
115. Maridakis V, Herring MP, O'Connor PJ. Sensitivity to change in cognitive performance and mood measures of energy and fatigue in response to differing doses of caffeine or breakfast. Int J Neurol. 2009;119:975-994.
116. Adan A, Serra-Grabulosa JM. Effects of caffeine and glucose, alone and combined, on cognitive performance. Hum Psychopharmacol 2010;25:310-317.
117. Souissi M, Abedelmalek S, Chtourou H, etal. Effects of morning caffeine ingestion on mood states, simple reaction time, and short-term maximal performance on elite judoists. Asian J Sports Med. 2012;3:161-168.
118. Smith AP, Rusted JM, Eaton-Williams P, etal. Effects of caffeine given before and after lunch on sustained attention. Neuropsychobiology. 1990;23:160-163.
119. Smith AP, Rusted JM, Savory M, etal. The effects of caffeine, impulsivity and time of day on performance, mood and cardiovascular function. J Psychopharmacol. 1991;5:120-128.
120. Borland RG, Rogers AS, Nicholson AN, etal. Performance overnight in shiftworkers operating a day-night schedule. Aviat Space Environ Med. 1986;57:241-249.
121. Muehlbach MJ, Walsh JK. The effects of caffeine on simulated night-shift work and subsequent daytime sleep. Sleep. 1995;18:22-29.
122. Jay SM, Petrilli RM, Ferguson SA, etal. The suitability of a caffeinated energy drink for night-shift workers. Physiol Behav. 2006;87:925-931.
123. Wyatt JK, Cajochen C, Ritz-De Cecco A, etal. Low-dose repeated caffeine administration for circadian-phase-dependent performance degradation during extended wakefulness. Sleep. 2004;27:374-381.
124. Shearer WT, Reuben JM, Mullington JM, etal. Soluble TNF-α receptor 1 and IL-6 plasma levels in humans subjected to the sleep deprivation model of spaceflight. J Allergy Clin Immunol. 2001;107:165-170.
125. Van Dongen HP, Price NJ, Mullington JM, etal. Caffeine eliminates psychomotor vigilance deficits from sleep inertia. Sleep. 2001;24:813-819.
126. Einother SJ, Giesbrecht T. Caffeine as an attention enhancer: reviewing existing assumptions. Psychopharmacology 2013;225:251-274.
127. Dinges DF, Powell JW. Microcomputer analyses of performance on a portable, simple visual RT task during sustained operations. Behav Res Methods Instrum Comput. 1985;17:652-655.
128. Wechsler D. Wechsler Adult Intelligence Scale-Revised. New York: Psychological Corp; 1981.
129. Dinges DF, Kribbs NB, Bates BL, etal. A very brief probed-recall memory task: sensitivity to sleep loss [Annual Meeting of the Sleep Research Society, abstract 330]. Sleep Res. 1993;22:330.
130. Newman RA, Kamimori GH, Wesensten NJ, etal. Caffeine gum minimizes sleep inertia. Percept Mot Skills. 2013;116:280-293.
131. Hayashi M, Masuda A, Hori T. The alerting effects of caffeine, bright light and face washing after a short daytime nap. Clin Neurophysiol. 2003;114:2268-2278.
132. Smith AP. Caffeine at work. Hum Psychopharmacol. 2005;20:441-445.
133. Bonnet MH, Arand DL. The use of prophylactic naps and caffeine to maintain performance during a continuous operation. Ergonomics. 1994;37:1009-1020.
134. Bonnet MH, Arand DL. Impact of naps and caffeine on extended nocturnal performance. Physiol Behav. 1994;56:103-109.
135. Horne JA, Reyner LA. Counteracting driver sleepiness: effects of napping, caffeine, and placebo. Psychophysiology. 1996;33:306-309.
136. Reyner LA, Horne JA. Efficacy of a "functional energy drink" in counteracting driver sleepiness. Physiol Behav. 2002;75:331-335.
137. Zatz M, Heath JR. Calcium and photoentrainment in chick pineal cells revisited: effects of caffeine, thapsigargin, EGTA, and light on the melatonin rhythm. J Neurochem. 1995;65:1332-1341.
138. Pelissier AL, Gantenbein M, Bruguerolle B. Caffeine-induced modifications of heart rate, temperature, and motor activity circadian rhythms in rats. Physiol Behav. 1999;67:81-88.
139. Antle MC, Steen NM, Mistlberger RE. Adenosine and caffeine modulate circadian rhythms in the Syrian hamster. Neuroreport. 2001;12:2901-2905.
140. Ding JM, Buchanan GF, Tischkau SA, etal. A neuronal ryanodine receptor mediates light-induced phase delays of the circadian clock. Nature. 1998;394:381-384.
141. Oike H, Kobori M, Suzuki T, etal. Caffeine lengthens circadian rhythms in mice. Biochem Biophys Res Commun. 2011;410:654-658.
142. Diaz-Munoz M, Dent MA, Granados-Fuentes D, etal. Circadian modulation of the ryanodine receptor type 2 in the SCN of rodents. Neuroreport. 1999;10:481-486.
143. Watanabe A, Moriya T, Nisikawa Y, etal. Adenosine A1-receptor agonist attenuates the light-induced phase shifts and Fos expression in vivo and optic nerve stimulation-evoked field potentials in the suprachiasmatic nucleus in vitro. Brain Res. 1996;740:329-336.
144. Elliott KJ, Todd Weber E, Rea MA. Adenosine A1 receptors regulate the response of the hamster circadian clock to light. Eur J Pharmacol. 2001;414:45-53.
145. Sigworth LA, Rea MA. Adenosine A1 receptors regulate the response of the mouse circadian clock to light. Brain Res. 2003;960:246-251.
146. Feldman JF. Circadian periodicity in Neurospora: alteration by inhibitors of cyclic AMP phosphodiesterase. Science. 1975;190:789-790.
147. Sherman H, Gutman R, Chapnik N, etal. Caffeine alters circadian rhythms and expression of disease and metabolic markers. Int J Biochem Cell Biol. 2011;43:829-838.
148. Wright KP, Badia P, Myers BL, etal. Caffeine and light effects on nighttime melatonin and temperature levels in sleep-deprived humans. Brain Res 1997;747:78-84.
149. Goel N. Genetics of sleep timing, duration and homeostasis in humans. Sleep Med Clin. 2011;6:171-182.
150. Van Dongen HPA, Baynard MD, Maislin G, etal. Systematic interindividual differences in neurobehavioral impairment from sleep loss: evidence of trait-like differential vulnerability. Sleep. 2004;27:423-433.
151. Van Dongen HP, Maislin G, Dinges DF. Dealing with inter-individual differences in the temporal dynamics of fatigue and performance: importance and techniques. Aviat Space Environ Med. 2004;75(3 Suppl):A147-A154.
152. Goel N, Dinges DF. Predicting risk in space: genetic markers for differential vulnerability to sleep restriction. Acta Astronaut. 2012;77:207-213.
153. Kuna ST, Maislin G, Pack FM, etal. Heritability of performance deficit accumulation during acute sleep deprivation in twins. Sleep. 2012;35:1223-1233.
154. Rupp TL, Wesensten NJ, Balkin TJ. Trait-like vulnerability to total and partial sleep loss. Sleep. 2012;35:1163-1172.
155. Goel N, Dinges DF. Behavioral and genetic markers of sleepiness. J Clin Sleep Med. 2011;7(Suppl 5):S19-S21.
156. Groeger JA, Viola AU, Lo JC, etal. Early morning executive functioning during sleep deprivation is compromised by a PERIOD3 polymorphism. Sleep. 2008;31:1159-1167.
157. Viola AU, Archer SN, James LM, etal. PER3 polymorphism predicts sleep structure and waking performance. Curr Biol. 2007;17:613-618.
158. Vandewalle G, Archer SN, Wuillaume C, etal. Functional magnetic resonance imaging-assessed brain responses during an executive task depend on interaction of sleep homeostasis, circadian phase, and PER3 genotype. J Neurosci. 2009;29:7948-7956.
159. Lo JC, Groeger JA, Santhi N, etal. Effects of partial and acute total sleep deprivation on performance across cognitive domains, individuals and circadian phase. PLoS ONE. 2012;7:e45987. doi:10.1371/journal.pone.0045987.
160. Rupp TL, Wesensten NJ, Newman R, etal. PER3 and ADORA2A polymorphisms impact neurobehavioral performance during sleep restriction. J Sleep Res. 2013;22:160-165.
161. Goel N, Banks S, Mignot E, etal. DQB1*0602 predicts interindividual differences in physiologic sleep, sleepiness, and fatigue. Neurology. 2010;75:1509-1519.
162. Bodenmann S, Xu S, Luhmann UF, etal. Pharmacogenetics of modafinil after sleep loss: catechol-O-methyltransferase genotype modulates waking functions but not recovery sleep. Clin Pharmacol Ther. 2009;85:296-304.
163. Goel N, Banks S, Lin L, etal. Val158Met polymorphism associates with individual differences in sleep physiologic responses to chronic sleep loss. PLoS ONE. 2011;6:e29283. doi:10.1371/journal.pone.0029283.
164. Bachmann V, Klein C, Bodenmann S, etal. The BDNF Val66Met polymorphism modulates sleep intensity: EEG frequency- and state-specificity. Sleep. 2012;35:335-344.
165. Retey JV, Adam M, Honegger E, etal. A functional genetic variation of adenosine deaminase affects the duration and intensity of deep sleep in humans. Proc Natl Acad Sci U S A. 2005;102:15676-15681.
166. 2A receptor gene (ADORA2A) contributes to individual sensitivity to caffeine effects on sleep. Clin Pharmacol Ther. 2007;81:692-698.
167. Bachmann V, Klaus F, Bodenmann S, etal. Functional ADA polymorphism increases sleep depth and reduces vigilant attention in humans. Cereb Cortex. 2012;22:962-970.
168. Bodenmann S, Hohoff C, Freitag C, etal. Polymorphisms of ADORA2A modulate psychomotor vigilance and the effects of caffeine on neurobehavioural performance and sleep EEG after sleep deprivation. Br J Pharmacol. 2012;165:1904-1913.
169. Hollingworth H. The influence of caffeine alkaloid on the quality and amount of sleep. Am J Psychol. 1912;23:89-100.
170. Hettema JM, Corey LA, Kendler KS. A multivariate genetic analysis of the use of tobacco, alcohol, and caffeine in a population based sample of male and female twins. Drug Alcohol Depend. 1999;57:69-78.
171. Kendler KS, Prescott CA. Caffeine intake, tolerance, and withdrawal in women: a population-based twin study. Am J Psychiatry. 1999;156:223-228.
172. Luciano M, Kirk KM, Heath AC, etal. The genetics of tea and coffee drinking and preference for source of caffeine in a large community sample of Australian twins. Addiction. 2005;100:1510-1517.
173. Luciano M, Zhu G, Kirk KM, etal. "No thanks, it keeps me awake": the genetics of coffee-attributed sleep disturbance. Sleep. 2007;30:1378-1386.
174. Yang A, Palmer AA, de Wit H. Genetics of caffeine consumption and responses to caffeine. Psychopharmacology 2010;211:245-257.
175. Gunes A, Dahl ML. Variation in CYP1A2 activity and its clinical implications: influence of environmental factors and genetic polymorphisms. Pharmacogenomics. 2008;9:625-637.
176. 2A receptor is associated with habitual caffeine consumption. Am J Clin Nutr. 2007;86:240-244.
177. 2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology. 2003;28:1694-1702.
178. Childs E, Hohoff C, Deckert J, etal. Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology. 2008;33:2791-2800.
179. Rogers PJ, Hohoff C, Heatherley SV, etal. Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption. Neuropsychopharmacology. 2010;35:1973-1983.
180. Byrne EM, Johnson J, McRae AF, etal. A genome-wide association study of caffeine-related sleep disturbance: confirmation of a role for a common variant in the adenosine receptor. Sleep. 2012;35:967-975.
181. Happonen P, Voutilainen S, Tuomainen TP, etal. Catechol-O-methyltransferase gene polymorphism modifies the effect of coffee intake on incidence of acute coronary events. PLoS ONE. 2006;1:e117. doi:10.1371/journal.pone.0000117.
182. Lucassen EA, Rother KI, Cizza G. Interacting epidemics? Sleep curtailment, insulin resistance, and obesity. Ann N Y Acad Sci. 2012;1264:110-134.
183. Antunes LC, Levandovski R, Dantas G, etal. Obesity and shift work: chronobiological aspects. Nutr Res Rev. 2010;23:155-168.
184. Allison KC, Goel N, Ahima RS. Delayed timing of eating: impact on weight and metabolism. Curr Obes Rep. 2014;3:91-100.
185. Spaeth AM, Dinges DF, Goel N. Effects of experimental sleep restriction on weight gain, caloric intake, and meal timing in healthy adults. Sleep. 2013;36:981-990.
186. Greenberg JA, Boozer CN, Geliebter A. Coffee, diabetes, and weight control. Am J Clin Nutr. 2006;84:682-693.
187. Kovacs EM, Lejeune MP, Nijs I, etal. Effects of green tea on weight maintenance after body-weight loss. Br J Nutr. 2004;91:431-437.
188. Westerterp-Plantenga MS, Lejeune MP, Kovacs EM. Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes Res. 2005;13:1195-1204.
189. Greenberg JA, Axen KV, Schnoll R, etal. Coffee, tea and diabetes: the role of weight loss and caffeine. Int J Obes. 2005;29:1121-1129.
190. Lopez-Garcia E, van Dam RM, Rajpathak S, etal. Changes in caffeine intake and long-term weight change in men and women. Am J Clin Nutr. 2006;83:674-680.
191. Bray GA, Popkin BM. Calorie-sweetened beverages and fructose: what have we learned 10 years later. Pediatr Obes. 2013;8:242-248.
192. US Food and Drug Administration. FDA to investigate added caffeine. Available at: http://www.fda.gov/downloads/forconsumers/consumerupdates/ucm350740.pdf. Published May 2013. Accessed June 25, 2013.
193. Snel J, Lorist MM. Effects of caffeine on sleep and cognition. Prog Brain Res. 2011;190:105-117.
194. Dinges DF, Orne MT, Whitehouse WG, etal. Temporal placement of a nap for alertness: contributions of circadian phase and prior wakefulness. Sleep. 1987;10:313-329.
195. Ficca G, Axelsson J, Mollicone DJ, etal. Naps, cognition and performance. Sleep Med Rev. 2010;14:249-258.
196. Statland BE, Demas TJ. Serum caffeine half-lives - healthy subjects vs. patients having alcoholic hepatic disease. Am J Clin Pathol. 1980;73:390-393.
197. Hammami MM, Al-Gaai EA, Alvi S, etal. Interaction between drug and placebo effects: a cross-over balanced placebo design trial. Trials. 2010;11:1-10.
198. Magkos F, Kavouras SA. Caffeine use in sports, pharmacokinetics in man, and cellular mechanisms of action. Crit Rev Food Sci. 2005;45:535-562.
199. Hindmarch I, Rigney U, Stanley N, etal. A naturalistic investigation of the effects of day-long consumption of tea, coffee and water on alertness, sleep onset and sleep quality. Psychopharmacology. 2000;149:203-216.
200. Roehrs T, Roth T. Caffeine: sleep and daytime sleepiness. Sleep Med Rev. 2008;12:153-162.
201. Calamaro CJ, Mason TB, Ratcliffe SJ. Adolescents living the 24/7 lifestyle: effects of caffeine and technology on sleep duration and daytime functioning. Pediatrics. 2009;123:e1005-e1010.
202. Carrier J, Paquet J, Fernandez-Bolanos M, etal. Effects of caffeine on daytime recovery sleep: a double challenge to the sleep-wake cycle in aging. Sleep Med. 2009;10:1016-1024.
203. Paterson LM, Nutt DJ, Ivarsson M, etal. Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers. J Psychopharmacol. 2009;23:487-494.
204. Lodato F, Araujo J, Barros H, etal. Caffeine intake reduces sleep duration in adolescents. Nutr Res. 2013;33:726-732.
205. Judelson DA, Armstrong LE, Sokmen B, etal. Effect of chronic caffeine intake on choice reaction time, mood, and visual vigilance. Physiol Behav. 2005;85:629-634.
206. Addicott MA, Laurienti PJ. A comparison of the effects of caffeine following abstinence and normal caffeine use. Psychopharmacology. 2009;207:423-431.
207. Kennedy DO, Haskell CF. Cerebral blood flow and behavioural effects of caffeine in habitual and non-habitual consumers of caffeine: a near infrared spectroscopy study. Biol Psychol. 2011;86:298-306.
208. Rogers PJ, Heatherley SV, Mullings EL, etal. Faster but not smarter: effects of caffeine and caffeine withdrawal on alertness and performance. Psychopharmacology. 2013;226:229-240.